Lv1
100 积分 2025-05-21 加入
Add-On Treatment With Zilebesiran for Inadequately Controlled Hypertension: The KARDIA-2 Randomized Clinical Trial
1个月前
已完结
Chronic kidney disease
2个月前
已关闭
The expanding landscape of genetic causes of obesity
3个月前
已完结
FGF21 promotes longevity in diet-induced obesity through metabolic benefits independent of growth suppression
7个月前
已完结
Approaching a therapeutic inflection point for FLT3-mutated AML
7个月前
已完结